
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
buprenorphine Hydrochloride Injection
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
buprenorphine Hydrochloride Injection Quick Finder
INDICATIONS AND USAGE
Buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
...WARNINGS
Addiction, Abuse, and Misuse
Buprenorphine hydrochloride contains buprenorphine, a Schedule III controlled substance. As an opioid, buprenorphine...
ADVERSE REACTIONS
The most frequent side effect in clinical studies involving 1,133 patients was sedation which occurred in approximately two-thirds of the patients. Although sedated, these patients could easily be aroused...
DRUG ABUSE AND DEPENDENCE
Controlled Substance
Buprenorphine hydrochloride contains buprenorphine, a Schedule III controlled substance.
OVERDOSAGE
Clinical Presentation
Acute overdose with buprenorphine hydrochloride can be manifested by respiratory depression, somnolence progressing to stupor or coma...
DESCRIPTION
Buprenorphine hydrochloride is a partial opioid agonist.
The chemical name of buprenorphine hydrochloride is 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy 18,19-dihydro-3-hydroxy-6-methoxy-α-...
CLINICAL PHARMACOLOGY
Mechanism of Action
Buprenorphine is a partial agonist at the mµ-opioid receptor and an antagonist at the kappa-opioid receptor. One unusual...
Instructions for Use of the Syringe Systems
Instructions for using the Carpuject™ Syringe are available with the reusable Carpuject™ Holder, List 2049-02.
Carpuject™ Single-dose cartridges are to be used ONLY with...
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
(800)-332-1088.